Tuesday, January 11, 2022

< + > Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Doctors demanded the FDA revoke its approval for the Alzheimer’s drug Aduhelm, which can cause side effects like brain bleeding.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > What's behind EHR-induced clinician burnout? And how to solve it?

When evaluating electronic health record systems to minimize documentation burden, usability is always the big challenge, says one informati...